Graphical description of the fitting parameters. by Kai Roecker (847195)

Subjects:

<i>HSpeed</i> results overview. by Kai Roecker (847195)

Subjects:

Groups of power-profile curve fittings. by Kai Roecker (847195)

Subjects:

Mean ± SD values for the parameters found with fittings of Eq. 8, S1 Appendix) to the relationship between time duration of movement (<i>t</i>_<i>dur</i>) and maximum hor... by Kai Roecker (847195)

Subjects:

Inactivation of MnuA and 5′-NT reduced bacterial fitness and virulence of <i>M</i>. <i>bovis</i> PG45 in mammary glands. by Aga E. Gelgie (17661720)

Independence of the lower against the upper asymptotes. by Kai Roecker (847195)

Subjects:

VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

“…Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10^-5), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10^-5), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10^-22), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10^-71), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10^-28), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10^-12), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10^-10) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10^-17). …”

Dox-inducible expression of HA-MAD1 in colon is sufficient to decrease p53 expression and cause chromosome missegregation. by Sarah E. Copeland (13951506)

“…Large circles show mean of cells from 5 fields of view from a single animal. (D) Immunoblot showing p53 protein expression is decreased in colon tissue from 5-month old HA-MAD1 mice after 1 week of 6 mg/kg dox feed as compared to control. …”

Hydroxymethylnitrofurazone (NFOH) decreases parasitaemia, parasitism and tissue lesion caused by infection with the Bolivia Trypanosoma cruzi type I strain in Swiss and C57BL/6 mic... by Cauê Benito Scarim (5222987)

“…Therefore, the results shown here pointing to the NFOH as promising compound for further preclinical studies, being a high potential drug to effective and safe chemotherapy to Chagas disease.…”

MeV induced <i>APOBEC3A</i> upregulation. by Pierre Khalfi (7868252)

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…After 4 weeks, when the tumor size was approximately 100 mm³ (T₀) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”

The shortened version of the Edinburgh Handedness Inventory encompasses 4 items (e.g. writing) scored on a 5-point scale ranging from:” Always right; usually right; both equally; u... by Marcel F. Hinss (14675457)

Genes showing 1.5 fold expression decrease in D381 relative to heterozygous <i>TOR1/tor1</i>. by Wanjun Qi (5571359)

Removal of <i>Mcs5c</i> TCE copies results in decreased <i>Pappa</i> expression <i>in vitro</i>. by Amanda N. Henning (3043851)

Treatment with blocking 10G7 but not with non-blocking 10F3 decreases overall virus loads as determined by whole body imaging. by Ren-Huan Xu (190315)

Invasion of <i>P. falciparum</i> strain Dd2 decreases as untreated RBCs are replaced with enzyme treated RBCs. by Martha A. Clark (322102)

Western blots and semiquantitative analysis of Claudin-5, VEGF-A, PIK3R2, P-Akt/Akt in cerebral ischemic penumbra between groups. by Guangxiao Ni (19713106)

Subjects:

V3Nter decreases colony formation and induces tumor cell death in HCT116 and HepG2 cells. by Delphine Quélard (43727)

Comparison in baseline variables between efficacy group and non-efficacy group. by Naruyoshi Gyoutoku (22537831)

Subjects:

Point cloud fusion instance effect. by Hongliang Zou (20707270)

Subjects: